Birdshot Chorioretinitis in Patients Aged 80 and Older.
Ocul Immunol Inflamm
; : 1-6, 2023 May 19.
Article
em En
| MEDLINE
| ID: mdl-37204866
ABSTRACT
PURPOSE:
To assess the manifestations of birdshot chorioretinitis (BSCR) in patients aged 80 and over.DESIGN:
Among patients with BSCR followed in the CO-BIRD prospective cohort (ClinicalTrials.gov Identifier NCT05153057), we analyzed the subgroup of patients aged 80 and over.METHODS:
Patients were assessed in a standardized manner. Confluent atrophy was defined as hypoautofluorescent spots on fundus autofluorescence (FAF).RESULTS:
We included 39 (8.8%) of the 442 enrolled CO-BIRD patients. The mean age was 83.8 ± 3.7 years. The mean logMAR BCVA was 0.52 ± 0.76, with 30 patients (76.9%) having 20/40 or better in at least one eye. Thirty-five (89.7%) patients were receiving no treatment. Confluent atrophy in the posterior pole, disrupted retrofoveal ellipsoid zone and choroidal neovascularization were associated with logMAR BCVA >0.3 (p < .0001).CONCLUSION:
In patients aged 80 and over we observed a striking heterogeneity of outcomes, but most retained a BCVA that allowed them to drive.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Ocul Immunol Inflamm
Assunto da revista:
ALERGIA E IMUNOLOGIA
/
OFTALMOLOGIA
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
França